`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`MEDTRONIC, INC., AND MEDTRONIC VASCULAR, INC.,
`Petitioner,
`
`v.
`
`TELEFLEX INNOVATIONS S.À.R.L.,
`Patent Owner.
`
`
`Case IPR2020-00132
`Patent RE 45,760
`
`
`
`PETITIONERS’ OBJECTIONS UNDER 37 C.F.R. § 42.64 TO PATENT
`OWNER’S PRE-INSTITUTION EVIDENCE
`
`
`
`IPR2020-00132
`Patent RE 45,760
`
`
`
`Pursuant to 37 C.F.R. § 42.64(b)(1), Petitioners Medtronic, Inc. and
`
`Medtronic Vascular, Inc. (“Medtronic”), hereby submit the following objections to
`
`certain evidence filed by Patent Owner Teleflex Innovations S.À.R.L (“Teleflex”)
`
`in conjunction with its Patent Owner Preliminary Response.
`
`I.
`
`
`
`Exhibits 2001, 2015, 2046, 2074: Declarations/Transcript of Howard Root
`
`Medtronic has yet to cross-examine Mr. Root, but intends to do so in
`
`advance of DUE DATE 2. Medtronic therefore reserves the right to move to
`
`exclude Exhibits 2001, 2015, 2046, 2074 and/or any testimony therein on the bases
`
`of FRE 401/402 (relevance), FRE 403 (probative value outweighed by prejudice,
`
`confusing, waste of time), FRE 602 (lack of personal knowledge), FRE 701
`
`(opinion by lay witness), and FRE 702/703 (insufficient support for expert
`
`testimony). In addition, Medtronic objects to Exhibits 2001, 2015, 2046, and 2074
`
`under FRE 802 (hearsay) to the extent Medtronic does not have the opportunity to
`
`cross-examine Mr. Root regarding his declaration/transcript.
`
`II. Exhibits 2002-2011, 2013-2014, 2016-2038, 2040-2041, 2058, 2061-2063,
`2065-2067: Documents/Evidence Submitted with Mr. Root Declaration
`
`Medtronic objects under FRE 106 (completeness), FRE 401/402 (relevance),
`
`
`
`FRE 403 (probative value outweighed by prejudice, confusing, waste of time),
`
`FRE 802 (hearsay), FRE 901 (authenticity), and FRE 1002 (requirement for
`
`original).
`
`
`
`
`
`1
`
`
`
`IPR2020-00132
`Patent RE 45,760
`
`III. Exhibit 2039: Declaration of Deborah Schmalz
`
`Medtronic has yet to cross-examine Ms. Schmalz, but intends to do so in
`
`advance of DUE DATE 2. Medtronic therefore reserves the right to move to
`
`exclude Exhibit 2039 and/or any testimony therein on the bases of FRE 401/402
`
`(relevance), FRE 403 (probative value outweighed by prejudice, confusing, waste
`
`of time), FRE 602 (lack of personal knowledge), FRE 701 (opinion by lay
`
`witness), and FRE 702/703 (insufficient support for expert testimony). In addition,
`
`Medtronic objects to Exhibit 2039 under FRE 802 (hearsay) to the extent
`
`Medtronic does not have the opportunity to cross-examine Ms. Schmalz regarding
`
`her declaration.
`
`IV. Exhibits 2043-2044: Declarations of Amy Welch
`
`Medtronic has yet to cross-examine Ms. Welch, but intends to do so in
`
`advance of DUE DATE 2. Medtronic therefore reserves the right to move to
`
`exclude Exhibits 2043-2044 and/or any testimony therein on the bases of FRE
`
`401/402 (relevance), FRE 403 (probative value outweighed by prejudice,
`
`confusing, waste of time), FRE 602 (lack of personal knowledge), FRE 701
`
`(opinion by lay witness), and FRE 702/703 (insufficient support for expert
`
`testimony). Further, Medtronic objects to Exhibits 2043-2044 under FRE 106
`
`(completeness) and FRE 1002 (requirement for original). In addition, Medtronic
`
`objects to Exhibits 2043-2044 under FRE 802 (hearsay) to the extent Medtronic
`
`
`
`2
`
`
`
`IPR2020-00132
`Patent RE 45,760
`
`does not have the opportunity to cross-examine Ms. Welch regarding her
`
`declaration.
`
`V.
`
`Exhibit 2042, 2056 & 2072: Expert Report/Declaration of Peter T. Keith
`
`Medtronic has yet to cross-examine Mr. Keith, but intends to do so in advance
`
`of DUE DATE 2. Medtronic therefore reserves the right to move to exclude
`
`Exhibits 2042, 2056, and 2072 and/or any testimony therein on the bases of FRE
`
`401/402 (relevance), FRE 403 (probative value outweighed by prejudice,
`
`confusing, waste of time), FRE 602 (lack of personal knowledge), FRE 701
`
`(opinion by lay witness), and FRE 702/703 (insufficient support for expert
`
`testimony). In addition, Medtronic objects to Exhibits 2042, 2056, and 2072 under
`
`FRE 802 (hearsay) to the extent Medtronic does not have the opportunity to cross-
`
`examine Mr. Keith regarding his expert report/declaration.
`
`VI. Exhibits 2057, 2060: Teleflex Website
`
`
`
`Medtronic objects under FRE 106 (completeness), FRE 401/402 (relevance),
`
`FRE 403 (probative value outweighed by prejudice, confusing, waste of time),
`
`hearsay (FRE 802), and FRE 901 (authenticity).
`
`VII. Exhibits 2069 & 2071: Exhibits to Complaint
`
`
`
`Medtronic objects under FRE 106 (completeness), FRE 401/402 (relevance),
`
`FRE 403 (probative value outweighed by prejudice, confusing, waste of time), and
`
`hearsay (FRE 802).
`
`
`
`3
`
`
`
`IPR2020-00132
`Patent RE 45,760
`
`VIII. Exhibit 2070: Guide Catheters
`
`Medtronic objects under FRE 106 (completeness), FRE 401/402 (relevance),
`
`FRE 403 (probative value outweighed by prejudice, confusing, waste of time),
`
`hearsay (FRE 802), FRE 901 (authenticity), and FRE 1002 (requirement for
`
`original).
`
`IX. Exhibit 2073: Declaration of Alexander S. Rinn
`
`Medtronic has yet to cross-examine Mr. Rinn, but intends to do so in advance
`
`of DUE DATE 2. Medtronic therefore reserves the right to move to exclude
`
`Exhibit 2073 and/or any testimony therein on the bases of FRE 602 (lack of
`
`personal knowledge), FRE 401/402 (relevance), and FRE 403 (probative value
`
`outweighed by prejudice, confusing, waste of time). In addition, Medtronic objects
`
`to Exhibit 2073 under FRE 802 (hearsay) to the extent Medtronic does not have the
`
`opportunity to cross-examine Mr. Rinn regarding his declaration.
`
`X.
`
`Exhibits 2045, 2048-2051, 2053-2054, 2059: Litigation Documents
`
`
`
`Medtronic objects under FRE 106 (completeness), FRE 401/402 (relevance),
`
`and/or FRE 403 (probative value outweighed by prejudice, confusing, waste of
`
`time).
`
`XI. Exhibit 2055: Surface Article
`
` Medtronic objects under FRE 106 (completeness), FRE 401/402 (relevance),
`
`FRE 403 (probative value outweighed by prejudice, confusing, waste of time),
`
`
`
`4
`
`
`
`IPR2020-00132
`Patent RE 45,760
`
`FRE 802 (hearsay), FRE 901 (authenticity), and FRE 1002 (requirement for
`
`
`
`Respectfully submitted,
`
`
`
`/Cyrus A. Morton/
`Cyrus A. Morton
`Reg. No. 44,954
`Robins Kaplan LLP
`2800 LaSalle Plaza
`800 LaSalle Avenue
`Minneapolis, MN 55402
`Attorney for Patent Owner
`
`original).
`
`Dated: June 22, 2020
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`5
`
`
`
`IPR2020-00132
`Patent RE 45,760
`
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 C.F.R. § 42.6(e)(4), the undersigned certifies that on June 22,
`
`2020, a copy of PETITIONERS’ OBJECTIONS UNDER 37 C.F.R. § 42.64 TO
`
`PATENT OWNER’S PRE-INSTITUTION EVIDENCE was served in its entirety
`
`by electronic mail on Patent Owner’s counsel at the following addresses indicated
`
`in Patent Owner’s Mandatory Notices:
`
`J. Derek Vandenburgh, Reg. No. 32,179
`dvandenburgh@carlsoncaspers.com
`
`Dennis C. Bremer, Reg. No. 40,528
`dbremer@carlsoncaspers.com
`
`
`
`Dated: June 22, 2020
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`/Cyrus A. Morton/
`Cyrus A. Morton
`Reg. No. 44,954
`Robins Kaplan LLP
`2800 LaSalle Plaza
`800 LaSalle Avenue
`Minneapolis, MN 55402
`Attorney for Patent Owner
`
`6
`
`